Animal models of airway inflammation and airway smooth muscle remodelling in asthma

Pulmonary Pharmacology and Therapeutics

Volumn 22, Issue 5, 2009, Pages 455-465

  Allen, Judith E ^b   Bischof, Robert J ^a   Sucie Chang, Herng Yu ^c   Hirota, Jeremy A ^d   Hirst, Stuart J ^e   Inman, Mark D ^d   Mitzner, Wayne ^c   Sutherland, Tara E ^b  

^a Department of Physiology School of Biomedical Sciences   (Australia)

^b Institute of Structural and Molecular Biology   (United Kingdom)

^c JOHNS HOPKINS UNIVERSITY   (United States)

^d MCMASTER UNIVERSITY   (Canada)

^e MONASH UNIVERSITY   (Australia)

Author keywords

Airway inflammation; Airway remodelling; Airway smooth muscle; Animal model; Asthma

Indexed keywords

ANTIASTHMATIC AGENT; CORTICOSTEROID; ESTRADIOL BENZOATE; ESTROGEN; GLUCOCORTICOID; MEDROXYPROGESTERONE ACETATE; METHACHOLINE; ORAL CONTRACEPTIVE AGENT; OVALBUMIN; PROGESTERONE; SEX HORMONE;

AIRWAY; AIRWAY SMOOTH MUSCLE; ARTICLE; ASTHMA; CAT; DISEASE MODEL; DOG; DRUG EFFECT; DRUG TARGETING; FEMALE; HORMONE ACTION; HORSE; IMMUNE SYSTEM; INFLAMMATION; LUNG FUNCTION; MALE; NONHUMAN; ORAL CONTRACEPTION; PRIMATE; PRIORITY JOURNAL; SEX DIFFERENCE; SHEEP; SMOOTH MUSCLE; STEROID THERAPY; SWINE;

ANIMALS; ASTHMA; DISEASE MODELS, ANIMAL; GONADAL STEROID HORMONES; HUMANS; IMMUNE SYSTEM; INFLAMMATION; INFLAMMATION MEDIATORS; MUSCLE, SMOOTH; RESPIRATORY SYSTEM; SEX CHARACTERISTICS;

EID: 69249212244     PISSN: 10945539     EISSN: 15229629     Source Type: Journal    
DOI: 10.1016/j.pupt.2009.04.001     Document Type: Article

References (229)

1. Holgate S.T. Pathogenesis of asthma. Clin Exp Allergy 38 6 (2008) 872-897
2. Kurucz I., and Szelenyi I. Current animal models of bronchial asthma. Curr Pharm Des 12 25 (2006) 3175-3194
3. Zosky G.R., and Sly P.D. Animal models of asthma. Clin Exp Allergy 37 7 (2007) 973-988
4. Kirschvink N., and Reinhold P. Use of alternative animals as asthma models. Curr Drug Targets 9 6 (2008) 470-484
5. Krug N., and Rabe K.F. Animal models for human asthma: the perspective of a clinician. Curr Drug Targets 9 6 (2008) 438-442
6. Kips J.C., Anderson G.P., Fredberg J.J., Herz U., Inman M.D., Jordana M., et al. Murine models of asthma. Eur Respir J 22 2 (2003) 374-382
7. Hein W.R., and Griebel P.J. A road less travelled: large animal models in immunological research. Nat Rev Immunol 3 1 (2003) 79-84
8. Fixman E.D., Stewart A., and Martin J.G. Basic mechanisms of development of airway structural changes in asthma. Eur Respir J 29 2 (2007) 379-389
9. Lloyd C.M., and Robinson D.S. Allergen-induced airway remodelling. Eur Respir J 29 5 (2007) 1020-1032
10. Pabst R. Animal models for asthma: controversial aspects and unsolved problems. Pathobiology 70 5 (2002) 252-254
11. Cates E.C., Fattouh R., Johnson J.R., Llop-Guevara A., and Jordana M. Modeling responses to respiratory house dust mite exposure. Contrib Microbiol 14 (2007) 42-67
12. Walters E.H., Reid D.W., Johns D.P., and Ward C. Nonpharmacological and pharmacological interventions to prevent or reduce airway remodelling. Eur Respir J 30 3 (2007) 574-588
13. Kumar R.K. Experimental models in pulmonary pathology. Pathology 27 2 (1995) 130-132
14. Kumar R.K., and Foster P.S. Modeling allergic asthma in mice: pitfalls and opportunities. Am J Respir Cell Mol Biol 27 3 (2002) 267-272
15. Nakajima H., and Takatsu K. Role of cytokines in allergic airway inflammation. Int Arch Allergy Immunol 142 4 (2007) 265-273
16. Chupp G.L., Lee C.G., Jarjour N., Shim Y.M., Holm C.T., He S., et al. A chitinase-like protein in the lung and circulation of patients with severe asthma. N Engl J Med 357 20 (2007) 2016-2027
17. Homer R.J. Airway remodeling and RELM-beta. Am J Physiol Lung Cell Mol Physiol 293 2 (2007) L303-L304
18. Pulichino A.M., Wang I.M., Caron A., Mortimer J., Auger A., Boie Y., et al. Identification of transforming growth factor beta1-driven genetic programs of acute lung fibrosis. Am J Respir Cell Mol Biol 39 3 (2008) 324-336
19. Kumar R.K., Herbert C., Yang M., Koskinen A.M., McKenzie A.N., and Foster P.S. Role of interleukin-13 in eosinophil accumulation and airway remodelling in a mouse model of chronic asthma. Clin Exp Allergy 32 7 (2002) 1104-1111
20. Nath P., Yee Leung S., Williams A.S., Noble A., Xie S., McKenzie A.N., et al. Complete inhibition of allergic airway inflammation and remodelling in quadruple IL-4/5/9/13-/- mice. Clin Exp Allergy 37 10 (2007) 1427-1435
21. Zheng T., Liu W., Oh S.Y., Zhu Z., Hu B., Homer R.J., et al. IL-13 receptor alpha2 selectively inhibits IL-13-induced responses in the murine lung. J Immunol 180 1 (2008) 522-529
22. Kumar R.K., Herbert C., Webb D.C., Li L., and Foster P.S. Effects of anticytokine therapy in a mouse model of chronic asthma. Am J Respir Crit Care Med 170 10 (2004) 1043-1048
23. Yang G., Volk A., Petley T., Emmell E., Giles-Komar J., Shang X., et al. Anti-IL-13 monoclonal antibody inhibits airway hyperresponsiveness, inflammation and airway remodeling. Cytokine 28 6 (2004) 224-232
24. Wynn T.A. Fibrotic disease and the T(H)1/T(H)2 paradigm. Nat Rev Immunol 4 8 (2004) 583-594
25. Zhu Z., Homer R.J., Wang Z., Chen Q., Geba G.P., Wang J., et al. Pulmonary expression of interleukin-13 causes inflammation, mucus hypersecretion, subepithelial fibrosis, physiologic abnormalities, and eotaxin production. J Clin Invest 103 6 (1999) 779-788
26. Mueller T.D., Zhang J.L., Sebald W., and Duschl A. Structure, binding, and antagonists in the IL-4/IL-13 receptor system. Biochim Biophys Acta 1592 3 (2002) 237-250
27. Komai M., Tanaka H., Masuda T., Nagao K., Ishizaki M., Sawada M., et al. Role of Th2 responses in the development of allergen-induced airway remodelling in a murine model of allergic asthma. Br J Pharmacol 138 5 (2003) 912-920
28. Jacobsen E.A., Taranova A.G., Lee N.A., and Lee J.J. Eosinophils: singularly destructive effector cells or purveyors of immunoregulation?. J Allergy Clin Immunol 119 6 (2007) 1313-1320
29. Tanaka H., Nagai H., and Maeda Y. Effect of anti-IL-4 and anti-IL-5 antibodies on allergic airway hyperresponsiveness in mice. Life Sci 62 13 (1998) PL169-PL174
30. Leigh R., Ellis R., Wattie J.N., Hirota J.A., Matthaei K.I., Foster P.S., et al. Type 2 cytokines in the pathogenesis of sustained airway dysfunction and airway remodeling in mice. Am J Respir Crit Care Med 169 7 (2004) 860-867
31. Humbles A.A., Lloyd C.M., McMillan S.J., Friend D.S., Xanthou G., McKenna E.E., et al. A critical role for eosinophils in allergic airways remodeling. Science 305 5691 (2004) 1776-1779
32. Gordon S. Alternative activation of macrophages. Nat Rev Immunol 3 1 (2003) 23-35
33. Loke P., Nair M.G., Parkinson J., Guiliano D., Blaxter M., and Allen J.E. IL-4 dependent alternatively-activated macrophages have a distinctive in vivo gene expression phenotype. BMC Immunol 3 (2002) 7
34. Noel W., Raes G., Hassanzadeh Ghassabeh G., De Baetselier P., and Beschin A. Alternatively activated macrophages during parasite infections. Trends Parasitol 20 3 (2004) 126-133
35. Raes G., Beschin A., Ghassabeh G.H., and De Baetselier P. Alternatively activated macrophages in protozoan infections. Curr Opin Immunol 19 4 (2007) 454-459
36. Loke P., MacDonald A.S., Robb A., Maizels R.M., and Allen J.E. Alternatively activated macrophages induced by nematode infection inhibit proliferation via cell-to-cell contact. Eur J Immunol 30 9 (2000) 2669-2678
37. Nair M.G., Gallagher I.J., Taylor M.D., Loke P., Coulson P.S., Wilson R.A., et al. Chitinase and Fizz family members are a generalized feature of nematode infection with selective upregulation of Ym1 and Fizz1 by antigen-presenting cells. Infect Immun 73 1 (2005) 385-394
38. Reyes J.L., and Terrazas L.I. The divergent roles of alternatively activated macrophages in helminthic infections. Parasite Immunol 29 12 (2007) 609-619
39. Anthony R.M., Urban Jr. J.F., Alem F., Hamed H.A., Rozo C.T., Boucher J.L., et al. Memory T(H)2 cells induce alternatively activated macrophages to mediate protection against nematode parasites. Nat Med 12 8 (2006) 955-960
40. Loke P., Gallagher I., Nair M.G., Zang X., Brombacher F., Mohrs M., et al. Alternative activation is an innate response to injury that requires CD4+ T cells to be sustained during chronic infection. J Immunol 179 6 (2007) 3926-3936
41. Diaz A., and Allen J.E. Mapping immune response profiles: the emerging scenario from helminth immunology. Eur J Immunol 37 12 (2007) 3319-3326
42. Graham A.L., Allen J.E., and Read A.F. Evolutionary causes and consequences of immunopathology. Annu Rev Ecol Evol Syst 36 (2005) 373-397
43. Chang N.C., Hung S.I., Hwa K.Y., Kato I., Chen J.E., Liu C.H., et al. A macrophage protein, Ym1, transiently expressed during inflammation is a novel mammalian lectin. J Biol Chem 276 20 (2001) 17497-17506
44. Migliaccio C.T., Buford M.C., Jessop F., and Holian A. The IL-4R{alpha} pathway in macrophages and its potential role in silica-induced pulmonary fibrosis. J Leukoc Biol 83 3 (2008) 630-639
45. Liu T., Dhanasekaran S.M., Jin H., Hu B., Tomlins S.A., Chinnaiyan A.M., et al. FIZZ1 stimulation of myofibroblast differentiation. Am J Pathol 164 4 (2004) 1315-1326
46. Liu T., Jin H., Ullenbruch M., Hu B., Hashimoto N., Moore B., et al. Regulation of found in inflammatory zone 1 expression in bleomycin-induced lung fibrosis: role of IL-4/IL-13 and mediation via STAT-6. J Immunol 173 5 (2004) 3425-3431
47. Yamaji-Kegan K., Su Q., Angelini D.J., Champion H.C., and Johns R.A. Hypoxia-induced mitogenic factor has proangiogenic and proinflammatory effects in the lung via VEGF and VEGF receptor-2. Am J Physiol Lung Cell Mol Physiol 291 6 (2006) L1159-L1168
48. Prud'homme G.J. Pathobiology of transforming growth factor beta in cancer, fibrosis and immunologic disease, and therapeutic considerations. Lab Invest 87 11 (2007) 1077-1091
49. Endo M., Oyadomari S., Terasaki Y., Takeya M., Suga M., Mori M., et al. Induction of arginase I and II in bleomycin-induced fibrosis of mouse lung. Am J Physiol Lung Cell Mol Physiol 285 2 (2003) L313-L321
50. Matute-Bello G., Wurfel M.M., Lee J.S., Park D.R., Frevert C.W., Madtes D.K., et al. Essential role of MMP-12 in Fas-induced lung fibrosis. Am J Respir Cell Mol Biol 37 2 (2007) 210-221
51. Kitowska K., Zakrzewicz D., Konigshoff M., Chrobak I., Grimminger F., Seeger W., et al. Functional role and species-specific contribution of arginases in pulmonary fibrosis. Am J Physiol Lung Cell Mol Physiol 294 1 (2008) L34-L45
52. Mora A.L., Torres-Gonzalez E., Rojas M., Corredor C., Ritzenthaler J., Xu J., et al. Activation of alveolar macrophages via the alternative pathway in herpesvirus-induced lung fibrosis. Am J Respir Cell Mol Biol 35 4 (2006) 466-473
53. Zimmermann N., and Rothenberg M.E. The arginine-arginase balance in asthma and lung inflammation. Eur J Pharmacol 533 1-3 (2006) 253-262
54. Vercelli D. Arginase: marker, effector, or candidate gene for asthma?. J Clin Invest 111 12 (2003) 1815-1817
55. Yang M., Rangasamy D., Matthaei K.I., Frew A.J., Zimmmermann N., Mahalingam S., et al. Inhibition of arginase I activity by RNA interference attenuates IL-13-induced airways hyperresponsiveness. J Immunol 177 8 (2006) 5595-5603
56. Maarsingh H., Zaagsma J., and Meurs H. Arginine homeostasis in allergic asthma. Eur J Pharmacol 585 2-3 (2008) 375-384
57. Webb D.C., McKenzie A.N., and Foster P.S. Expression of the Ym2 lectin-binding protein is dependent on interleukin (IL)-4 and IL-13 signal transduction: identification of a novel allergy-associated protein. J Biol Chem 276 45 (2001) 41969-41976
58. Zhu Z., Zheng T., Homer R.J., Kim Y.K., Chen N.Y., Cohn L., et al. Acidic mammalian chitinase in asthmatic Th2 inflammation and IL-13 pathway activation. Science 304 5677 (2004) 1678-1682
59. Tong Q., Zheng L., Li B., Wang D., Huang C., Matuschak G.M., et al. Hypoxia-induced mitogenic factor enhances angiogenesis by promoting proliferation and migration of endothelial cells. Exp Cell Res 312 18 (2006) 3559-3569
60. Teng X., Li D., Champion H.C., and Johns R.A. FIZZ1/RELMalpha, a novel hypoxia-induced mitogenic factor in lung with vasoconstrictive and angiogenic properties. Circ Res 92 10 (2003) 1065-1067
61. Broide D.H. Immunologic and inflammatory mechanisms that drive asthma progression to remodeling. J Allergy Clin Immunol 121 3 (2008) 560-570 quiz 571-2
62. Anderson G.P. Endotyping asthma: new insights into key pathogenic mechanisms in a complex, heterogeneous disease. Lancet 372 9643 (2008) 1107-1119
63. Wenzel S., and Holgate S.T. The mouse trap: it still yields few answers in asthma. Am J Respir Crit Care Med 174 11 (2006) 1173-1176 discussion 1176-8
64. Matsumura Y. The effects of ozone, nitrogen dioxide, and sulfur dioxide on the experimentally induced allergic respiratory disorder in guinea pigs. I. The effect on sensitization with albumin through the airway. Am Rev Respir Dis 102 3 (1970) 430-437
65. Coyle A.J., Wagner K., Bertrand C., Tsuyuki S., Bews J., and Heusser C. Central role of immunoglobulin (Ig) E in the induction of lung eosinophil infiltration and T helper 2 cell cytokine production: inhibition by a non-anaphylactogenic anti-IgE antibody. J Exp Med 183 4 (1996) 1303-1310
66. Sur S., Lam J., Bouchard P., Sigounas A., Holbert D., and Metzger W.J. Immunomodulatory effects of IL-12 on allergic lung inflammation depend on timing of doses. J Immunol 157 9 (1996) 4173-4180
67. Campbell E.M., Kunkel S.L., Strieter R.M., and Lukacs N.W. Temporal role of chemokines in a murine model of cockroach allergen-induced airway hyperreactivity and eosinophilia. J Immunol 161 12 (1998) 7047-7053
68. Southam D.S., Dolovich M., O'Byrne P.M., and Inman M.D. Distribution of intranasal instillations in mice: effects of volume, time, body position, and anesthesia. Am J Physiol Lung Cell Mol Physiol 282 4 (2002) L833-L839
69. Southam D.S., Ellis R., Wattie J., and Inman M.D. Components of airway hyperresponsiveness and their associations with inflammation and remodeling in mice. J Allergy Clin Immunol 119 4 (2007) 848-854
70. Locke N.R., Royce S.G., Wainewright J.S., Samuel C.S., and Tang M.L. Comparison of airway remodeling in acute, subacute, and chronic models of allergic airways disease. Am J Respir Cell Mol Biol 36 5 (2007) 625-632
71. Leigh R., Ellis R., Wattie J., Southam D.S., De Hoogh M., Gauldie J., et al. Dysfunction and remodeling of the mouse airway persist after resolution of acute allergen-induced airway inflammation. Am J Respir Cell Mol Biol 27 5 (2002) 526-535
72. Wang Z.L., Walker B.A., Weir T.D., Yarema M.C., Roberts C.R., Okazawa M., et al. Effect of chronic antigen and beta 2 agonist exposure on airway remodeling in guinea pigs. Am J Respir Crit Care Med 152 6 Pt 1 (1995) 2097-2104
73. Panettieri Jr. R.A., Murray R.K., Eszterhas A.J., Bilgen G., and Martin J.G. Repeated allergen inhalations induce DNA synthesis in airway smooth muscle and epithelial cells in vivo. Am J Physiol 274 3 Pt 1 (1998) L417-L424
74. Salmon M., Walsh D.A., Koto H., Barnes P.J., and Chung K.F. Repeated allergen exposure of sensitized Brown-Norway rats induces airway cell DNA synthesis and remodelling. Eur Respir J 14 3 (1999) 633-641
75. Sapienza S., Du T., Eidelman D.H., Wang N.S., and Martin J.G. Structural changes in the airways of sensitized Brown Norway rats after antigen challenge. Am Rev Respir Dis 144 2 (1991) 423-427
76. Wang C.G., Du T., Xu L.J., and Martin J.G. Role of leukotriene D4 in allergen-induced increases in airway smooth muscle in the rat. Am Rev Respir Dis 148 2 (1993) 413-417
77. Xu K.F., Vlahos R., Messina A., Bamford T.L., Bertram J.F., and Stewart A.G. Antigen-induced airway inflammation in the Brown Norway rat results in airway smooth muscle hyperplasia. J Appl Physiol 93 5 (2002) 1833-1840
78. Johnson J.R., Wiley R.E., Fattouh R., Swirski F.K., Gajewska B.U., Coyle A.J., et al. Continuous exposure to house dust mite elicits chronic airway inflammation and structural remodeling. Am J Respir Crit Care Med 169 3 (2004) 378-385
79. Gratzner H.G. Monoclonal antibody to 5-bromo- and 5-iododeoxyuridine: a new reagent for detection of DNA replication. Science 218 4571 (1982) 474-475
80. Santoso A., Kaiser A., and Winter Y. Individually dosed oral drug administration to socially-living transponder-tagged mice by a water dispenser under RFID control. J Neurosci Methods 153 2 (2006) 208-213
81. Ramos-Barbon D., Presley J.F., Hamid Q.A., Fixman E.D., and Martin J.G. Antigen-specific CD4+ T cells drive airway smooth muscle remodeling in experimental asthma. J Clin Invest 115 6 (2005) 1580-1589
82. Hirota J.A., Ellis R., and Inman M.D. Regional differences in the pattern of airway remodeling following chronic allergen exposure in mice. Respir Res 7 1 (2006) 120
83. Halayko A.J., Stelmack G.L., Yamasaki A., McNeill K., Unruh H., and Rector E. Distribution of phenotypically disparate myocyte subpopulations in airway smooth muscle. Can J Physiol Pharmacol 83 1 (2005) 104-116
84. James A.L., and Wenzel S. Clinical relevance of airway remodelling in airway diseases. Eur Respir J 30 1 (2007) 134-155
85. Halayko A.J., Salari H., Ma X., and Stephens N.L. Markers of airway smooth muscle cell phenotype. Am J Physiol 270 6 Pt 1 (1996) L1040-L1051
86. Moir L.M., Leung S.Y., Eynott P.R., McVicker C.G., Ward J.P., Chung K.F., et al. Repeated allergen inhalation induces phenotypic modulation of smooth muscle in bronchioles of sensitized rats. Am J Physiol Lung Cell Mol Physiol 284 1 (2003) L148-L159
87. Ellis R., Leigh R., Southam D., O'Byrne P.M., and Inman M.D. Morphometric analysis of mouse airways after chronic allergen challenge. Lab Invest 83 9 (2003) 1285-1291
88. McVicker C.G., Leung S.Y., Kanabar V., Moir L.M., Mahn K., Chung K.F., et al. Repeated allergen inhalation induces cytoskeletal remodeling in smooth muscle from rat bronchioles. Am J Respir Cell Mol Biol 36 6 (2007) 721-727
89. Moorman J.E., Rudd R.A., Johnson C.A., King M., Minor P., Bailey C., et al. National surveillance for asthma - United States, 1980-2004. MMWR Surveill Summ 56 8 (2007) 1-54
90. de Marco R., Locatelli F., Sunyer J., and Burney P. Differences in incidence of reported asthma related to age in men and women. A retrospective analysis of the data of the European Respiratory Health Survey. Am J Respir Crit Care Med 162 1 (2000) 68-74
91. Tepper R.S., Morgan W.J., Cota K., Wright A., and Taussig L.M. Physiologic growth and development of the lung during the first year of life. Am Rev Respir Dis 134 3 (1986) 513-519
92. Agarwal A.K., and Shah A. Menstrual-linked asthma. J Asthma 34 6 (1997) 539-545
93. Mirdal G.M., Petersson B., Weeke B., and Vibits A. Asthma and menstruation: the relationship between psychological and bronchial hyperreactivity. Br J Med Psychol 71 Pt 1 (1998) 47-55
94. Gibbs C.J., Coutts I.I., Lock R., Finnegan O.C., and White R.J. Premenstrual exacerbation of asthma. Thorax 39 11 (1984) 833-836
95. Salter H.H. On asthma: its pathology and treatment (1882), William Wood and Company, New York
96. Frank R.T. The hormonal causes of premenstrual tension. Arch Neurol Psychiatry 26 (1931) 1053-1057
97. Israel S.L. Premenstrual tension. JAMA 110 21 (1938) 1721-1723
98. Rees L. Anaetiological study of premenstrual asthma. J Psychosom Res 52 (1963) 191-197
99. Zondek B., and Bromberg Y.M. Endocrine allergy I. Allergic sensitivity to endogenous hormones. J Allergy 16 (1945) 1-16
100. Barr R.G., and Camargo Jr. C.A. Hormone replacement therapy and obstructive airway diseases. Treat Respir Med 3 1 (2004) 1-7
101. Carlson C.L., Cushman M., Enright P.L., Cauley J.A., and Newman A.B. Hormone replacement therapy is associated with higher FEV1 in elderly women. Am J Respir Crit Care Med 163 2 (2001) 423-428
102. Haggerty C.L., Ness R.B., Kelsey S., and Waterer G.W. The impact of estrogen and progesterone on asthma. Ann Allergy Asthma Immunol 90 3 (2003) 284-291 quiz 291-3, 347
103. Hepburn M.J., Dooley D.P., and Morris M.J. The effects of estrogen replacement therapy on airway function in postmenopausal, asthmatic women. Arch Intern Med 161 22 (2001) 2717-2720
104. Lam S.M., and Huang S.C. Premenstrual asthma: report of a case with hormonal studies. J Microbiol Immunol Infect 31 3 (1998) 197-199
105. Lieberman D., Kopernik G., Porath A., Lazer S., and Heimer D. Sub-clinical worsening of bronchial asthma during estrogen replacement therapy in asthmatic post-menopausal women. Maturitas 21 2 (1995) 153-157
106. Lieberman D., Kopernic G., Porath A., Levitas E., Lazer S., and Heimer D. Influence of estrogen replacement therapy on airway reactivity. Respiration 62 4 (1995) 205-208
107. Matsuo N., Shimoda T., Matsuse H., and Kohno S. A case of menstruation-associated asthma: treatment with oral contraceptives. Chest 116 1 (1999) 252-253
108. Myers J.R., and Sherman C.B. Should supplemental estrogens be used as steroid-sparing agents in asthmatic women?. Chest 106 1 (1994) 318-319
109. Salam M.T., Wenten M., and Gilliland F.D. Endogenous and exogenous sex steroid hormones and asthma and wheeze in young women. J Allergy Clin Immunol 117 5 (2006) 1001-1007
110. Troisi R.J., Speizer F.E., Willett W.C., Trichopoulos D., and Rosner B. Menopause, postmenopausal estrogen preparations, and the risk of adult-onset asthma. A prospective cohort study. Am J Respir Crit Care Med 152 4 Pt 1 (1995) 1183-1188
111. Boulet L.P., Chakir J., Dube J., Laprise C., Boutet M., and Laviolette M. Airway inflammation and structural changes in airway hyper-responsiveness and asthma: an overview. Can Respir J 5 1 (1998) 16-21
112. Chang H.Y., and Mitzner W. Sex differences in mouse models of asthma. Can J Physiol Pharmacol 85 12 (2007) 1226-1235
113. Card J.W., Carey M.A., Bradbury J.A., DeGraff L.M., Morgan D.L., Moorman M.P., et al. Gender differences in murine airway responsiveness and lipopolysaccharide-induced inflammation. J Immunol 177 1 (2006) 621-630
114. Carey M.A., Card J.W., Bradbury J.A., Moorman M.P., Haykal-Coates N., Gavett S.H., et al. Spontaneous airway hyperresponsiveness in estrogen receptor-alpha-deficient mice. Am J Respir Crit Care Med 175 2 (2007) 126-135
115. Ahmed S.A., and Talal N. Sex hormones and the immune system - Part 2. Animal data. Baillieres Clin Rheumatol 4 1 (1990) 13-31
116. Balzano G., Fuschillo S., Melillo G., and Bonini S. Asthma and sex hormones. Allergy 56 1 (2001) 13-20
117. Bodel P., Dillard Jr. G.M., Kaplan S.S., and Malawista S.E. Anti-inflammatory effects of estradiol on human blood leukocytes. J Lab Clin Med 80 3 (1972) 373-384
118. Sunday L., Tran M.M., Krause D.N., and Duckles S.P. Estrogen and progestagens differentially modulate vascular proinflammatory factors. Am J Physiol Endocrinol Metab 291 2 (2006) E261-E267
119. Melgert B.N., Postma D.S., Kuipers I., Geerlings M., Luinge M.A., van der Strate B.W., et al. Female mice are more susceptible to the development of allergic airway inflammation than male mice. Clin Exp Allergy 35 11 (2005) 1496-1503
120. Corteling R., and Trifilieff A. Gender comparison in a murine model of allergen-driven airway inflammation and the response to budesonide treatment. BMC Pharmacol 4 (2004) 4
121. Matsubara S., Swasey C.H., Loader J.E., Dakhama A., Joetham A., Ohnishi H., et al. Estrogen determines gender differences in airway responsiveness after allergen exposure. Am J Respir Cell Mol Biol (2007)
122. Riffo-Vasquez Y., Ligeiro de Oliveira A.P., Page C.P., Spina D., and Tavares-de-Lima W. Role of sex hormones in allergic inflammation in mice. Clin Exp Allergy 37 3 (2007) 459-470
123. Miyaura H., and Iwata M. Direct and indirect inhibition of Th1 development by progesterone and glucocorticoids. J Immunol 168 3 (2002) 1087-1094
124. Mitchell V.L., and Gershwin L.J. Progesterone and environmental tobacco smoke act synergistically to exacerbate the development of allergic asthma in a mouse model. Clin Exp Allergy 37 2 (2007) 276-286
125. Hellings P.W., Vandekerckhove P., Claeys R., Billen J., Kasran A., and Ceuppens J.L. Progesterone increases airway eosinophilia and hyper-responsiveness in a murine model of allergic asthma. Clin Exp Allergy 33 10 (2003) 1457-1463
126. Perusquia M., Hernandez R., Montano L.M., Villalon C.M., and Campos M.G. Inhibitory effect of sex steroids on guinea-pig airway smooth muscle contractions. Comp Biochem Physiol C Pharmacol Toxicol Endocrinol 118 1 (1997) 5-10
127. de Oliveira A.P., Domingos H.V., Cavriani G., Damazo A.S., Dos Santos Franco A.L., Oliani S.M., et al. Cellular recruitment and cytokine generation in a rat model of allergic lung inflammation are differentially modulated by progesterone and estradiol. Am J Physiol Cell Physiol 293 3 (2007) C1120-C1128
128. Hai C.M. Airway smooth muscle cell as therapeutic target of inflammation. Curr Med Chem 14 1 (2007) 67-76
129. Persson C.G., Erjefalt J.S., Korsgren M., and Sundler F. The mouse trap. Trends Pharmacol Sci 18 12 (1997) 465-467
130. Gersch C., Dewald O., Zoerlein M., Michael L.H., Entman M.L., and Frangogiannis N.G. Mast cells and macrophages in normal C57/BL/6 mice. Histochem Cell Biol 118 1 (2002) 41-49
131. Schroder N.W., and Maurer M. The role of innate immunity in asthma: leads and lessons from mouse models. Allergy 62 6 (2007) 579-590
132. Moise N.S., Wiedenkeller D., Yeager A.E., Blue J.T., and Scarlett J. Clinical, radiographic, and bronchial cytologic features of cats with bronchial disease: 65 cases (1980-1986). J Am Vet Med Assoc 194 10 (1989) 1467-1473
133. Padrid P., Snook S., Finucane T., Shiue P., Cozzi P., Solway J., et al. Persistent airway hyperresponsiveness and histologic alterations after chronic antigen challenge in cats. Am J Respir Crit Care Med 151 1 (1995) 184-193
134. Kirschvink N., Leemans J., Delvaux F., Snaps F., Clercx C., and Gustin P. Functional, inflammatory and morphological characterisation of a cat model of allergic airway inflammation. Vet J 174 3 (2007) 541-553
135. Norris Reinero C.R., Decile K.C., Berghaus R.D., Williams K.J., Leutenegger C.M., Walby W.F., et al. An experimental model of allergic asthma in cats sensitized to house dust mite or Bermuda grass allergen. Int Arch Allergy Immunol 135 2 (2004) 117-131
136. Chapman R.W. Canine models of asthma and COPD. Pulm Pharmacol Ther (2008)
137. Ohrui T., Sekizawa K., Aikawa T., Yamauchi K., Sasaki H., and Takishima T. Vascular permeability and airway narrowing during late asthmatic response in dogs treated with metopirone. J Allergy Clin Immunol 89 5 (1992) 933-943
138. Sasaki H., Yanai M., Shimura S., Okayama H., Aikawa T., Sasaki T., et al. Late asthmatic response to Ascaris antigen challenge in dogs treated with metyrapone. Am Rev Respir Dis 136 6 (1987) 1459-1465
139. Woolley M.J., Lane C.G., Ellis R., Stevens W.H., Woolley K.L., and O'Byrne P.M. Role of airway eosinophils in the development of allergen-induced airway hyperresponsiveness in dogs. Am J Respir Crit Care Med 152 5 Pt 1 (1995) 1508-1512
140. Becker A.B., Hershkovich J., Simons F.E., Simons K.J., Lilley M.K., and Kepron M.W. Development of chronic airway hyperresponsiveness in ragweed-sensitized dogs. J Appl Physiol 66 6 (1989) 2691-2697
141. Chung K.F., Becker A.B., Lazarus S.C., Frick O.L., Nadel J.A., and Gold W.M. Antigen-induced airway hyperresponsiveness and pulmonary inflammation in allergic dogs. J Appl Physiol 58 4 (1985) 1347-1353
142. Fornhem C., Kumlin M., Lundberg J.M., and Alving K. Allergen-induced late-phase airways obstruction in the pig: mediator release and eosinophil recruitment. Eur Respir J 8 7 (1995) 1100-1109
143. Mitchell H.W., Turner D.J., Gray P.R., and McFawn P.K. Compliance and stability of the bronchial wall in a model of allergen-induced lung inflammation. J Appl Physiol 86 3 (1999) 932-937
144. Abraham WM. Modeling of asthma, COPD and cystic fibrosis in sheep. Pulm Pharmacol Ther 2008; 21:743-54.
145. Ware L.B. Modeling human lung disease in animals. Am J Physiol Lung Cell Mol Physiol 294 2 (2008) L149-L150
146. Abraham W.M., Delehunt J.C., Yerger L., and Marchette B. Characterization of a late phase pulmonary response after antigen challenge in allergic sheep. Am Rev Respir Dis 128 5 (1983) 839-844
147. Bischof R.J., Snibson K., Shaw R., and Meeusen E.N. Induction of allergic inflammation in the lungs of sensitized sheep after local challenge with house dust mite. Clin Exp Allergy 33 3 (2003) 367-375
148. Koumoundouros E., Bischof R.J., Meeusen E.N., Mareels I.M., and Snibson K.J. Chronic airway disease: deteriorating pulmonary function in sheep associated with repeated challenges of house dust mite. Exp Lung Res 32 7 (2006) 321-330
149. Snibson K.J., Bischof R.J., Slocombe R.F., and Meeusen E.N. Airway remodelling and inflammation in sheep lungs after chronic airway challenge with house dust mite. Clin Exp Allergy 35 2 (2005) 146-152
150. Bai T.R., and Knight D.A. Structural changes in the airways in asthma: observations and consequences. Clin Sci (Lond) 108 6 (2005) 463-477
151. Allegra L., Abraham W.M., Chapman G.A., and Wanner A. Duration of mucociliary dysfunction following antigen challenge. J Appl Physiol 55 3 (1983) 726-730
152. Mezey R.J., Cohn M.A., Fernandez R.J., Januszkiewicz A.J., and Wanner A. Mucociliary transport in allergic patients with antigen-induced bronchospasm. Am Rev Respir Dis 118 4 (1978) 677-684
153. Edsbacker S., Wollmer P., Selroos O., Borgstrom L., Olsson B., and Ingelf J. Do airway clearance mechanisms influence the local and systemic effects of inhaled corticosteroids?. Pulm Pharmacol Ther 21 2 (2008) 247-258
154. Driska S.P., Laudadio R.E., Wolfson M.R., and Shaffer T.H. A method for isolating adult and neonatal airway smooth muscle cells and measuring shortening velocity. J Appl Physiol 86 1 (1999) 427-435
155. Collie D.D. Comparative, complementary and relevant: the immunological basis of ovine lung allergic responses. Clin Exp Allergy 33 3 (2003) 282-286
156. Kariyawasam HH, Robinson DS. Airway remodelling in asthma: models and supermodels? Clin Exp Allergy 2005;35(2):117-21.
157. Leguillette R. Recurrent airway obstruction - heaves. Vet Clin North Am Equine Pract 19 1 (2003) 63-86 vi
158. Lowell F.C. Observations on heaves. An asthma-like syndrome in the horse. J Allergy Clin Immunol 35 (1964) 322-330
159. Thurlbeck W.M., and Lowell F.C. Heaves in horses. Am Rev Respir Dis 89 (1964) 82-88
160. Derksen F.J., Scott J.S., Miller D.C., Slocombe R.F., and Robinson N.E. Bronchoalveolar lavage in ponies with recurrent airway obstruction (heaves). Am Rev Respir Dis 132 5 (1985) 1066-1070
161. Kaup F.J., Drommer W., Damsch S., and Deegen E. Ultrastructural findings in horses with chronic obstructive pulmonary disease (COPD). II: pathomorphological changes of the terminal airways and the alveolar region. Equine Vet J 22 5 (1990) 349-355
162. Kaup F.J., Drommer W., and Deegen E. Ultrastructural findings in horses with chronic obstructive pulmonary disease (COPD). I: alterations of the larger conducting airways. Equine Vet J 22 5 (1990) 343-348
163. Herszberg B., Ramos-Barbon D., Tamaoka M., Martin J.G., and Lavoie J.P. Heaves, an asthma-like equine disease, involves airway smooth muscle remodeling. J Allergy Clin Immunol 118 2 (2006) 382-388
164. Weiszer I., Patterson R., and Pruzansky J.J. Ascaris hypersensitivity in the rhesus monkey. I. A model for the study of immediate type thypersensitity in the primate. J Allergy 41 1 (1968) 14-22
165. Schelegle E.S., Gershwin L.J., Miller L.A., Fanucchi M.V., Van Winkle L.S., Gerriets J.P., et al. Allergic asthma induced in rhesus monkeys by house dust mite (Dermatophagoides farinae). Am J Pathol 158 1 (2001) 333-341
166. Van Scott M.R., Hooker J.L., Ehrmann D., Shibata Y., Kukoly C., Salleng K., et al. Dust mite-induced asthma in cynomolgus monkeys. J Appl Physiol 96 4 (2004) 1433-1444
167. Yasue M., Nakamura S., Yokota T., Okudaira H., and Okumura Y. Experimental monkey model sensitized with mite antigen. Int Arch Allergy Immunol 115 4 (1998) 303-311
168. Ferreira F.D., Mayer P., Sperr W.R., Valent P., Seiberler S., Ebner C., et al. Induction of IgE antibodies with predefined specificity in rhesus monkeys with recombinant birch pollen allergens, Bet v 1 and Bet v 2. J Allergy Clin Immunol 97 1 Pt 1 (1996) 95-103
169. Plopper C.G., and Hyde D.M. The non-human primate as a model for studying COPD and asthma. Pulm Pharmacol Ther (2008)
170. Coffman R.L., and Hessel E.M. Nonhuman primate models of asthma. J Exp Med 201 12 (2005) 1875-1879
171. Fanucchi M.V., Schelegle E.S., Baker G.L., Evans M.J., McDonald R.J., Gershwin L.J., et al. Immunostimulatory oligonucleotides attenuate airways remodeling in allergic monkeys. Am J Respir Crit Care Med 170 11 (2004) 1153-1157
172. Tran M.U., Weir A.J., Fanucchi M.V., Rodriguez A.E., Pantle L.M., Smiley-Jewell S.M., et al. Smooth muscle hypertrophy in distal airways of sensitized infant rhesus monkeys exposed to house dust mite allergen. Clin Exp Allergy 34 10 (2004) 1627-1633
173. Holt P.G., Batty J.E., and Turner K.J. Inhibition of specific IgE responses in mice by pre-exposure to inhaled antigen. Immunology 42 3 (1981) 409-417
174. Careau E., Sirois J., and Bissonnette E.Y. Characterization of lung hyperresponsiveness, inflammation, and alveolar macrophage mediator production in allergy resistant and susceptible rats. Am J Respir Cell Mol Biol 26 5 (2002) 579-586
175. Huh J.C., Strickland D.H., Jahnsen F.L., Turner D.J., Thomas J.A., Napoli S., et al. Bidirectional interactions between antigen-bearing respiratory tract dendritic cells (DCs) and T cells precede the late phase reaction in experimental asthma: DC activation occurs in the airway mucosa but not in the lung parenchyma. J Exp Med 198 1 (2003) 19-30
176. Handley D.A., DeLeo J.J., and Havill A.M. Induction by aerosol allergen of sustained and nonspecific IgE-mediated airway hyperreactivity in the guinea pig. Agents Actions 37 3-4 (1992) 201-203
177. Redman T.K., Rudolph K., Barr E.B., Bowen L.E., Muggenburg B.A., and Bice D.E. Pulmonary immunity to ragweed in a Beagle dog model of allergic asthma. Exp Lung Res 27 5 (2001) 433-451
178. Eder C., Crameri R., Mayer C., Eicher R., Straub R., Gerber H., et al. Allergen-specific IgE levels against crude mould and storage mite extracts and recombinant mould allergens in sera from horses affected with chronic bronchitis. Vet Immunol Immunopathol 73 3-4 (2000) 241-253
179. Schmallenbach K.H., Rahman I., Sasse H.H., Dixon P.M., Halliwell R.E., McGorum B.C., et al. Studies on pulmonary and systemic Aspergillus fumigatus-specific IgE and IgG antibodies in horses affected with chronic obstructive pulmonary disease (COPD). Vet Immunol Immunopathol 66 3-4 (1998) 245-256
180. Trifilieff A., El-Hashim A., and Bertrand C. Time course of inflammatory and remodeling events in a murine model of asthma: effect of steroid treatment. Am J Physiol Lung Cell Mol Physiol 279 6 (2000) L1120-L1128
181. Takeda K., Haczku A., Lee J.J., Irvin C.G., and Gelfand E.W. Strain dependence of airway hyperresponsiveness reflects differences in eosinophil localization in the lung. Am J Physiol Lung Cell Mol Physiol 281 2 (2001) L394-L402
182. Lewis C.A., Johnson A., and Broadley K.J. Early and late phase bronchoconstrictions in conscious sensitized guinea-pigs after macro- and microshock inhalation of allergen and associated airway accumulation of leukocytes. Int J Immunopharmacol 18 6-7 (1996) 415-422
183. Mauser P.J., Pitman A., Witt A., Fernandez X., Zurcher J., Kung T., et al. Inhibitory effect of the TRFK-5 anti-IL-5 antibody in a guinea pig model of asthma. Am Rev Respir Dis 148 6 Pt 1 (1993) 1623-1627
184. Bos I.S., Gosens R., Zuidhof A.B., Schaafsma D., Halayko A.J., Meurs H., et al. Inhibition of allergen-induced airway remodelling by tiotropium and budesonide: a comparison. Eur Respir J 30 4 (2007) 653-661
185. Fornhem C., Peterson C.G., Dahlback M., Scheynius A., and Alving K. Granulocyte function in the airways of allergen-challenged pigs: effects of inhaled and systemic budesonide. Clin Exp Allergy 26 12 (1996) 1436-1448
186. Fornhem C., Peterson C.G., Scheynius A., and Alving K. Influence of endogenous cortisol on eosinophil function in sensitized pigs: direct measurements of eosinophil peroxidase. Clin Exp Allergy 26 4 (1996) 469-478
187. Abraham W.M., Sielczak M.W., Wanner A., Perruchoud A.P., Blinder L., Stevenson J.S., et al. Cellular markers of inflammation in the airways of allergic sheep with and without allergen-induced late responses. Am Rev Respir Dis 138 6 (1988) 1565-1571
188. Gundel R.H., Gerritsen M.E., Gleich G.J., and Wegner C.D. Repeated antigen inhalation results in a prolonged airway eosinophilia and airway hyperresponsiveness in primates. J Appl Physiol 68 2 (1990) 779-786
189. Gundel R.H., Wegner C.D., and Letts L.G. Antigen-induced acute and late-phase responses in primates. Am Rev Respir Dis 146 2 (1992) 369-373
190. Miller H.R., and Pemberton A.D. Tissue-specific expression of mast cell granule serine proteinases and their role in inflammation in the lung and gut. Immunology 105 4 (2002) 375-390
191. Wyss D., Bonneau O., and Trifilieff A. Mast cell involvement in the adenosine mediated airway hyper-reactivity in a murine model of ovalbumin-induced lung inflammation. Br J Pharmacol 145 7 (2005) 845-852
192. Yu M., Tsai M., Tam S.Y., Jones C., Zehnder J., and Galli S.J. Mast cells can promote the development of multiple features of chronic asthma in mice. J Clin Invest 116 6 (2006) 1633-1641
193. Graziano F.M., Tilton R., Hirth T., Segaloff D., Mullins T., Dick E., et al. The effect of parainfluenza 3 infection on guinea pig basophil and lung mast cell histamine release. Am Rev Respir Dis 139 3 (1989) 715-720
194. Salari H., Howard S., Chan H., Dryden P., and Chan-Yeung M. Involvement of immunologic mechanisms in a guinea pig model of western red cedar asthma. J Allergy Clin Immunol 93 5 (1994) 877-884
195. Hogan S.P., Koskinen A., Matthaei K.I., Young I.G., and Foster P.S. Interleukin-5-producing CD4+ T cells play a pivotal role in aeroallergen-induced eosinophilia, bronchial hyperreactivity, and lung damage in mice. Am J Respir Crit Care Med 157 1 (1998) 210-218
196. Lapa e Silva J.R., Ruffie C., Vargaftig B.B., and Pretolani M. Modulation of the bronchial inflammation in sensitized guinea-pigs by FK506, nedocromil sodium and dexamethasone. Eur Respir J 8 8 (1995) 1321-1327
197. Cordeau M.E., Joubert P., Dewachi O., Hamid Q., and Lavoie J.P. IL-4, IL-5 and IFN-gamma mRNA expression in pulmonary lymphocytes in equine heaves. Vet Immunol Immunopathol 97 1-2 (2004) 87-96
198. Lavoie J.P., Maghni K., Desnoyers M., Taha R., Martin J.G., and Hamid Q.A. Neutrophilic airway inflammation in horses with heaves is characterized by a Th2-type cytokine profile. Am J Respir Crit Care Med 164 8 Pt 1 (2001) 1410-1413
199. Debrue M., Hamilton E., Joubert P., Lajoie-Kadoch S., and Lavoie J.P. Chronic exacerbation of equine heaves is associated with an increased expression of interleukin-17 mRNA in bronchoalveolar lavage cells. Vet Immunol Immunopathol 105 1-2 (2005) 25-31
200. Dewachi O., Joubert P., Hamid Q., and Lavoie J.P. Expression of interleukin (IL)-5 and IL-9 receptors on neutrophils of horses with heaves. Vet Immunol Immunopathol 109 1-2 (2006) 31-36
201. Souza D.J., Gundel R.H., Barton R.W., Stearns C.D., Torcellini C.A., Miner E.J., et al. Changes in T lymphocyte subsets and activation following chronic antigen inhalations in monkeys. Chest 103 2 Suppl. (1993) 132S-133S
202. Tulic M.K., Holt P.G., and Sly P.D. Modification of acute and late-phase allergic responses to ovalbumin with lipopolysaccharide. Int Arch Allergy Immunol 129 2 (2002) 119-128
203. Turner D.J., Myron P., Powell W.S., and Martin J.G. The role of endogenous corticosterone in the late-phase response to allergen challenge in the Brown Norway rat. Am J Respir Crit Care Med 153 2 (1996) 545-550
204. Hutson P.A., Holgate S.T., and Church M.K. Inhibition by nedocromil sodium of early and late phase bronchoconstriction and airway cellular infiltration provoked by ovalbumin inhalation in conscious sensitized guinea-pigs. Br J Pharmacol 94 1 (1988) 6-8
205. ten Berge R.E., Santing R.E., Hamstra J.J., Roffel A.F., and Zaagsma J. Dysfunction of muscarinic M2 receptors after the early allergic reaction: possible contribution to bronchial hyperresponsiveness in allergic guinea-pigs. Br J Pharmacol 114 4 (1995) 881-887
206. Dain D., and Gold W.M. Mechanical properties of the lungs and experimental asthma in conscious allergic dogs. J Appl Physiol 38 1 (1975) 96-100
207. Alving K., Matran R., Lacroix J.S., and Lundberg J.M. Capsaicin and histamine antagonist-sensitive mechanisms in the immediate allergic reaction of pig airways. Acta Physiol Scand 138 1 (1990) 49-60
208. Gundel R.H., Kinkade P., Torcellini C.A., Clarke C.C., Watrous J., Desai S., et al. Antigen-induced mediator release in primates. Am Rev Respir Dis 144 1 (1991) 76-82
209. de Bie J.J., Kneepkens M., Kraneveld A.D., Jonker E.H., Henricks P.A., Nijkamp F.P., et al. Absence of late airway response despite increased airway responsiveness and eosinophilia in a murine model of asthma. Exp Lung Res 26 7 (2000) 491-507
210. Zosky G.R., Larcombe A.N., White O.J., Burchell J.T., Janosi T.Z., Hantos Z., et al. Ovalbumin-sensitized mice are good models for airway hyperresponsiveness but not acute physiological responses to allergen inhalation. Clin Exp Allergy 38 5 (2008) 829-838
211. Pirie R.S., Collie D.D., Dixon P.M., and McGorum B.C. Inhaled endotoxin and organic dust particulates have synergistic proinflammatory effects in equine heaves (organic dust-induced asthma). Clin Exp Allergy 33 5 (2003) 676-683
212. Bellofiore S., and Martin J.G. Antigen challenge of sensitized rats increases airway responsiveness to methacholine. J Appl Physiol 65 4 (1988) 1642-1646
213. Blyth D.I., Pedrick M.S., Savage T.J., Bright H., Beesley J.E., and Sanjar S. Induction, duration, and resolution of airway goblet cell hyperplasia in a murine model of atopic asthma: effect of concurrent infection with respiratory syncytial virus and response to dexamethasone. Am J Respir Cell Mol Biol 19 1 (1998) 38-54
214. McMillan S.J., and Lloyd C.M. Prolonged allergen challenge in mice leads to persistent airway remodelling. Clin Exp Allergy 34 3 (2004) 497-507
215. Temelkovski J., Hogan S.P., Shepherd D.P., Foster P.S., and Kumar R.K. An improved murine model of asthma: selective airway inflammation, epithelial lesions and increased methacholine responsiveness following chronic exposure to aerosolised allergen. Thorax 53 10 (1998) 849-856
216. Cui Z.H., Skoogh B.E., Pullerits T., and Lotvall J. Bronchial hyperresponsiveness and airway wall remodelling induced by exposure to allergen for 9 weeks. Allergy 54 10 (1999) 1074-1082
217. Zhang X., Yao W., and He Q. [Image analysis of airway remodeling and responsiveness in asthmatic guinea pig]. Zhonghua Jie He He Hu Xi Za Zhi 24 2 (2001) 87-89
218. Bloemen K., Verstraelen S., Van Den Heuvel R., Witters H., Nelissen I., and Schoeters G. The allergic cascade: review of the most important molecules in the asthmatic lung. Immunol Lett 113 1 (2007) 6-18
219. Mauad T., Bel E.H., and Sterk P.J. Asthma therapy and airway remodeling. J Allergy Clin Immunol 120 5 (2007) 997-1009 quiz 1010-1
220. Roth M., and Black J.L. Transcription factors in asthma: are transcription factors a new target for asthma therapy?. Curr Drug Targets 7 5 (2006) 589-595
221. Caramori G., Groneberg D., Ito K., Casolari P., Adcock I.M., and Papi A. New drugs targeting Th2 lymphocytes in asthma. J Occup Med Toxicol 3 Suppl. 1 (2008) S6
222. Wegmann M. Animal models of chronic experimental asthma - strategies for the identification of new therapeutic targets. J Occup Med Toxicol 3 Suppl. 1 (2008) S4
223. Borger P., Tamm M., Black J.L., and Roth M. Asthma: is it due to an abnormal airway smooth muscle cell?. Am J Respir Crit Care Med 174 4 (2006) 367-372
224. Danek C.J., Lombard C.M., Dungworth D.L., Cox P.G., Miller J.D., Biggs M.J., et al. Reduction in airway hyperresponsiveness to methacholine by the application of RF energy in dogs. J Appl Physiol 97 5 (2004) 1946-1953
225. Brown R.H., Wizeman W., Danek C., and Mitzner W. Effect of bronchial thermoplasty on airway distensibility. Eur Respir J 26 2 (2005) 277-282
226. Cox G. New interventions in asthma including bronchial thermoplasty. Curr Opin Pulm Med 14 1 (2008) 77-81
227. Cox G., Thomson N.C., Rubin A.S., Niven R.M., Corris P.A., Siersted H.C., et al. Asthma control during the year after bronchial thermoplasty. N Engl J Med 356 13 (2007) 1327-1337
228. Lazaar A.L., and Panettieri Jr. R.A. Airway smooth muscle as an immunomodulatory cell: a new target for pharmacotherapy?. Curr Opin Pharmacol 1 3 (2001) 259-264
229. Beckett P.A., and Howarth P.H. Pharmacotherapy and airway remodelling in asthma?. Thorax 58 2 (2003) 163-174